Compare Coursera Inc (COUR) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Coursera Inc vs Zoetis Inc — how do they compare? Coursera Inc trades at $5.16 (market cap $1.39B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 21.7× Coursera Inc's market cap, and Zoetis Inc pays a 2.9% dividend while Coursera Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Coursera Inc for 47 Days and Zoetis Inc for 70 Days on average.
| COUR | ZTS | |
|---|---|---|
Market Cap | $1.39B | $30.20B |
Volume | 9,728,980 | 6,175,327 |
Sector | Consumer Staples | Health |
52-Week High | $10.73 | $147.53 |
52-Week Low | $4.64 | $69.09 |
Typical Hold Time | 47 Days | 70 Days |
Enterprise Value | $648.49M | $37.76B |
Dividend Yield | — | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
COUR trades at $5.27, up 3.13% today, with a mixed technical picture showing a bullish overall signal but bearish moving averages. Revenue growth is solid, rising from $524M in 2022 to $758M in 2025, yet the company remains unprofitable with a net loss of $51M in 2025. Recent news highlights AI platform developments and institutional interest, including large call option purchases and a new stake by Deutsche Bank AG.
The outlook is cautiously optimistic, driven by revenue growth and analyst consensus favoring a buy with a $7.40 price target. However, persistent losses, integration risks from acquisitions, and competitive pressures in edtech pose significant risks. Upside depends on converting subscriber growth into profitability.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Coursera Inc
Coursera Inc is a global online learning platform that offers anyone, anywhere access to online courses and degrees from world-class universities and companies. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The platform will contain a catalog of high-quality content and credentials, content developed by leading university and industry partners, data and machine learning drive personalized Learning, effective marketing, and skills Benchmarking and others.
Read more on COUR →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
